{"organizations": [], "uuid": "b427bb47d11fffe4b7c0f6625ed09368d899b6e2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-scythian-biosciences-corp-announce/brief-scythian-biosciences-corp-announces-approval-for-listing-on-the-nasdaq-capital-markets-under-symbol-scyb-idUSFWN1Q4196", "country": "US", "domain_rank": 408, "title": "BRIEF-Scythian Biosciences Corp Announces Approval For Listing On The Nasdaq Capital Markets Under Symbol \"Scyb\"", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T15:53:00.000+02:00", "replies_count": 0, "uuid": "b427bb47d11fffe4b7c0f6625ed09368d899b6e2"}, "author": "", "url": "https://www.reuters.com/article/brief-scythian-biosciences-corp-announce/brief-scythian-biosciences-corp-announces-approval-for-listing-on-the-nasdaq-capital-markets-under-symbol-scyb-idUSFWN1Q4196", "ord_in_thread": 0, "title": "BRIEF-Scythian Biosciences Corp Announces Approval For Listing On The Nasdaq Capital Markets Under Symbol \"Scyb\"", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "nasdaq capital markets under symbol", "sentiment": "negative"}, {"name": "brief-scythian biosciences corp", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "scythian biosciences corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 57 PM / Updated 11 minutes ago BRIEF-Scythian Biosciences Corp Announces Approval For Listing On The Nasdaq Capital Markets Under Symbol \"Scyb\" Reuters Staff 1 Min Read Feb 14 (Reuters) - Scythian Biosciences Corp: * SCYTHIAN BIOSCIENCES CORP. ANNOUNCES APPROVAL FOR LISTING ON THE NASDAQ CAPITAL MARKETS UNDER SYMBOL “SCYB” AND RINGING OF THE NASDAQ CLOSING BELL Source text for Eikon:  ", "external_links": [], "published": "2018-02-14T15:53:00.000+02:00", "crawled": "2018-02-14T16:12:43.002+02:00", "highlightTitle": ""}